首页 | 本学科首页   官方微博 | 高级检索  
     


Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
Authors:M. Rosario  N. L. Dirks  M. R. Gastonguay  A. A. Fasanmade  T. Wyant  A. Parikh  W. J. Sandborn  B. G. Feagan  W. Reinisch  I. Fox
Affiliation:1. Takeda Pharmaceuticals International Co., Cambridge, MA, USA;2. Metrum Research Group LLC, Tariffville, CT, USA;3. Takeda Pharmaceuticals International, Inc., Deerfield, IL, USA;4. Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA;5. Robarts Research Institute, University of Western Ontario, London, ON, Canada;6. Department Internal Medicine III, Medical University of Vienna, Vienna, Austria;7. Department of Internal Medicine, McMaster University, Hamilton, ON, Canada
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号